Care of elderly cancer patients has improved over recent years; however, younger patients in Europe still survive longer than more elderly patients, and the difference cannot be accounted for by the higher likelihood of dying [more]
Cancer policy is determined by opinions not evidence, with the loudest voice setting the agenda. This is the worry of Richard Sullivan, who is on a mission to open the discussion to voices beyond the [more]
Less invasive than surgery and less toxic than systemic therapy, will the fast-growing specialty of interventional radiology join the big three’ as the fourth pillar of cancer care? Looking at the specialists in the front-line [more]
Is the centralisation of cancer services justified? Could many cancers be treated more locally without compromising safety? Cancer World’s Anna Wagstaff posed this question to two experts: Susan O’Reilly and Renée Otter. In an effort [more]
At a time when the British media has been under the spotlight for its for poor ethical standards, The Independent’s Big Tobacco Exposed series shows why good investigative journalism remains so important in opening powerful [more]
Targeted drugs can result in a variety of skin toxicities that are unpleasant for patients and, if unattended to, can lead them to stop taking their drug as prescribed. Effective teamwork is required to ensure [more]
Smartphones give patients the technology not only to record a consultation but also to share it privately, post it on a social network or even upload it to a public website. What does this mean [more]
Addition of aprepitant, an NK-1 receptor antagonist, to dexamethasone and a 5-HT3 receptor antagonist contributes substantially to emetic control in patients receiving five-day cisplatin-containing chemotherapy, a new trial shows. Some needs in antiemetic therapy remain [more]
My World Jacob Scott uses approaches from his previous life as a physicist and engineer to build models of cancer biology and evolution from first principles, in the hope of generating novel, translatable hypotheses. On [more]
Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we [more]
Patients are being let down by a failure to integrate the knowledge we have to get the best possible results for each individual patient and for cancer patients as a whole. Vincenzo Valentini, the ESTRO [more]
The odds that a woman will be told she needs a reoperation after conservative breast surgery vary between treatment centres, prompting calls for international guidelines and greater oversight of surgeons. For many women with [more]
Cancer poses a rising threat to global health as well as the world economy. International experts have agreed on a strategy that can meet the challenge. They are now calling on world leaders to wake [more]